Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

The best words in the best order.

Nature·2011

Same author

Career decisions: Taking the plunge.

Nature·2011

Same author

Protein-protein interactions: Interactome under construction.

Nature·2010

Same author

Protein-protein interactions: Tools for the search.

Nature·2010

Same author

Protein-protein interactions: Real-time analysis.

Nature·2010

Same author

Biomedical science: Putting research into practice.

Nature·2010

Search research articles

Video Experimental Relacionado

Updated: Jun 25, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Terapéutica basada en ARN: ¿Listo para la entrega?

|February 26, 2009

Resumen

Las terapias basadas en ARN son prometedoras para el tratamiento de enfermedades, pero la entrega efectiva a los tejidos objetivo sigue siendo un desafío. Los ensayos clínicos en curso y los estudios en animales indican un futuro positivo para estas terapias avanzadas.

Área de la Ciencia:

Biotecnología La biotecnología es la biotecnología.
La medicina molecular es una medicina molecular.
Sistemas de suministro de drogas Sistemas de suministro de drogas.

Sus antecedentes:

Las terapias basadas en ARN, incluyendo mRNA y siRNA, tienen un potencial significativo para el tratamiento de diversas enfermedades.
La administración eficiente y dirigida de terapias de ARN a tejidos específicos es un desafío crítico que dificulta la aplicación clínica.

Objetivo del estudio:

Revisar el panorama actual y las perspectivas futuras de las terapias basadas en ARN.
Para resaltar los desafíos y avances en la administración de terapias de ARN específicas para tejidos.

Principales métodos:

Revisión de la literatura científica actual y los datos de ensayos clínicos.
Análisis de estudios preclínicos en modelos animales centrados en los mecanismos de entrega de ARN.

Más Videos Relacionados

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Videos de Experimentos Relacionados

Last Updated: Jun 25, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Principales resultados:

Varias estrategias terapéuticas basadas en ARN están progresando a través de ensayos clínicos.
Los avances en las tecnologías de entrega están mostrando una promesa en los modelos preclínicos para la distribución de tejidos dirigidos.

Conclusiones:

A pesar de los obstáculos de entrega, el campo de las terapias basadas en ARN está avanzando rápidamente.
La investigación y el desarrollo futuros en sistemas de administración son cruciales para realizar todo el potencial terapéutico de los medicamentos basados en ARN.